Skip to content

Clinical trials

Anemia, Refractory, with Excess of Blasts trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Country / region: Italy Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20101
20132
20141
20151
20181
20191
20204
20211
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Terminated3
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Italiana Sindromi Mielodisplastiche-ETS4
European Organisation for Research and Treatment of Cancer - EORTC3
Traws Pharma, Inc.3
Advice Pharma Group srl1
Celgene1
European Institute of Oncology1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Gruppo Italiano Trapianto di Midollo Osseo1
Incyte Corporation1
Istituto Clinico Humanitas1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts19
Myelodysplastic Syndromes10
Leukemia, Myeloid, Acute6
Leukemia, Myelomonocytic, Chronic5
Anemia, Refractory3
Leukemia3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Myeloproliferative Disorders3
Cytopenia2
Hematologic Diseases2

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.